chevron_leftBack
As of 8 June 2026, MedMira Inc. has a market cap of $27.67M USD, ranking #34813 globally and #1178 in Canada.
It ranks #3141 in the Healthcare sector, and #669 in the Medical Devices industry.
Key Stats
Market Cap
$27.67MUSD
38.6M CAD
Enterprise Value
$40.07MUSD
55.89M CAD
Revenue (TTM)
$135.13KUSD
188.5K CAD
EBITDA (TTM)
-$1.72MUSD
-2.4M CAD
Net Income (TTM)
-$2.51MUSD
-3.49M CAD
PS Ratio
204.8
PB Ratio
-1.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Hermes Chan
open_in_new
Employees
52
Founded
1993
Website
medmira.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | -8.3% | -8.3% | -15% | -35% | -39% |
Upcoming Earnings
Earnings Date
Mon, Jun 29
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
MIR
MedMira Inc
ISIN: CA58501R1029
Shares Out.:
Shares Outstanding:
701.731M1
Shares Float:
209.719M2
|
0.0550 CAD | |
|
MIR
MedMira Inc
ISIN: CA58501R1029
|
0.0550 CAD | |
|
MMIRF
MedMira Inc
ISIN: CA58501R1029
Shares Out.:
Shares Outstanding:
697.666M1
Shares Float:
243.804M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0496 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About MedMira Inc.
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: BLCO
|
$5.47B
20K%
|
-
|
|
TSX: EDT
|
$290.28M
949%
404.92M CAD
|
-
|
|
TSX: PRN
|
$238.87M
763%
333.22M CAD
|
-
|
|
TSXV: TLT
|
$64.23M
132%
89.6M CAD
|
-
|
|
TSXV: COV
|
$37.42M
35%
52.2M CAD
|
55.0
|
|
TSXV: PINK
|
$31.69M
15%
44.2M CAD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
626K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
581K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
575K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
457K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
436K%
|
38.3
|
|
NYSE: MDT
|
$101.9B
368K%
|
22.2
|
chevron_leftBack